癌症和免疫表型的综合性基因定型通过长时间阅读测序
Livius Penter1,2,3,4,5, Mehdi Borji1,2,6, Adi Nagler1,2
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Nature communications
|January 3, 2024
概括
纳米oranger是一种新的长期阅读的测序方法,通过检测单细胞cDNA库中的遗传条形码来增强细胞谱系的识别. 这种方法改善了在急性髓性白血病 (AML) 等疾病中细胞进化的跟踪.
科学领域:
- 基因组学就是基因组学.
- 分子生物学分子生物学
- 生物信息学是一种生物信息学.
背景情况:
- 单细胞转录组学对于细胞类型和细胞状态的分类至关重要.
- 整合基因型信息可以改善细胞谱系的识别.
- 短读测序限制了自然遗传条形码的检测,需要复杂的方法.
研究的目的:
- 开发一个灵活的长读测序工作流程和分析管道 (nanoranger) 进行增强的细胞系鉴定.
- 检测多种细胞谱系定义特征,包括遗传变异和融合基因.
- 根据转录属性优化纳米猩猩的目标选择.
主要方法:
- 一个长时间阅读的测序工作流程,从中间单细胞cDNA库开始.
- 一个分析管道 (纳米 oranger) 检测单核酸变体,融合基因,异型和TCR / 化学抗原序列.
- 系统分析以确定最佳目标位置 (高度表达的基因的5'末端,转录长度<4kB).
主要成果:
- 纳米人成功地从单细胞cDNA中检测出各种自然遗传条形码.
- 纳米猩猩的最佳目标被确定为特定的基因位置.
- 适用于急性髓性白血病 (AML) 证明了纵向亚克隆跟踪.
- 免疫细胞的异质异构形态景观的特征.
结论:
- 纳米提供了一种灵活和有效的方法,用于使用长读序列的细胞基因定型.
- 该方法增强了细胞谱系定义特征的识别.
- 纳米子可以改善单细胞瘤和免疫细胞共同进化的跟踪.
相关概念视频
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...


